Food-poisoning bacteria may be behind Crohn’s disease

The study's results means that new diagnostic tools should be developed to identify AIEC-colonized individuals who may be at greater risk for Crohn's disease following an episode of acute infectious gastroenteritis.

October 12, 2016

crohn_1

Expert Featured In This Story

Brian Coombes
Brian Coombes

Professor

See Profile

People who retain a particular bacterium in their gut after a bout of food poisoning may be at an increased risk of developing Crohn’s disease later in life, according to a new study led by researchers at McMaster University.

Using a mouse model of Crohn’s disease, the researchers discovered that acute infectious gastroenteritis caused by common food-poisoning bacteria accelerates the growth of adherent-invasive E. coli (AIEC) – a bacterium that has been linked to the development of Crohn’s.

Even after the mice had eliminated the food-poisoning bacteria, researchers still observed increased levels of AIEC in the gut, which led to worsened symptoms over a long period of time.

The study, published in the journal PLOS Pathogens, was funded by grants from the Canadian Institutes of Health Research and Crohn’s and Colitis Canada.

Crohn’s disease is a debilitating bowel disease characterized by the inflammation of the intestines. Today, one in every 150 Canadians is living with Crohn’s or colitis, a rate that ranks among the highest worldwide.

“This is a lifelong disease that often strikes people in their early years, leading to decades of suffering, an increased risk of colorectal cancer, and an increased risk of premature death,” said Brian Coombes, senior author of the study. At McMaster University he is a professor of biochemistry and biomedical sciences and a researcher at the Michael G. DeGroote Institute for Infectious Disease Research.

The study’s results, said Coombes, means that new diagnostic tools should be developed to identify AIEC-colonized individuals who may be at greater risk for Crohn’s disease following an episode of acute infectious gastroenteritis.   

“We need to understand the root origins of this disease – and to use this information to invigorate a new pipeline of treatments and preventions. It has never been more pressing.”

Marcy McCall MacBain, Susan Tighe, Jen Heisz and McMaster students chat with an older adult who is working out in a gym setting.

$50M McCall MacBain Foundation gift propels McMaster’s leadership in helping people live longer in good health

The largest philanthropic gift to kinesiology in Canadian university history supports a long-term vision for global healthspan research, education, health policy and community impact.
Four researchers stand together, smiling, in a lab.

Key protein in Parkinson’s disease behaves differently in blood and brain, McMaster study shows

Insights from the study of protein alpha-synuclein could lead to earlier detection of the neurogenerative disease.
Two smiling researchers wearing lab coats, in a laboratory.

McMaster researcher’s latest antibiotic discovery offers new way to kill drug-resistant bacteria

Manikomycin, which blocks the exit site of the protein-producing machinery in bacteria, is the fourth major discovery from antimicrobial resistance expert Gerry Wright’s research team in recent months.